                         SEQUENCE LISTING

<110>  THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
       Kirichok, Yuriy
       Bertholet, Ambre
       Grabe, Michael
       Bisignano, Paola
       Natale, Andrew
 
<120>  METHODS AND COMPOSITIONS FOR TREATING METABOLIC DISORDERS

<130>  048536-659001WO

<150>  US 63/056,350
<151>  2020-07-24

<160>  9     

<170>  PatentIn version 3.5

<210>  1
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic polynucleotide


<220>
<221>  misc_feature
<222>  (1)..(24)

<400>  1
gccagcctct cctgatttta gtgt                                              24


<210>  2
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic polynucleotide


<220>
<221>  misc_feature
<222>  (1)..(24)

<400>  2
gggaacacaa aagacctctt ctgg                                              24


<210>  3
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic polynucleotide


<220>
<221>  misc_feature
<222>  (1)..(20)

<400>  3
ctagcagaaa caaaccgggc                                                   20


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic polynucleotide


<220>
<221>  misc_feature
<222>  (1)..(20)

<400>  4
ccggctgcgt attctacgtt                                                   20


<210>  5
<211>  298
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<222>  (1)..(298)

<400>  5

Met Gly Asp His Ala Trp Ser Phe Leu Lys Asp Phe Leu Ala Gly Gly 
1               5                   10                  15      


Val Ala Ala Ala Val Ser Lys Thr Ala Val Ala Pro Ile Glu Arg Val 
            20                  25                  30          


Lys Leu Leu Leu Gln Val Gln His Ala Ser Lys Gln Ile Ser Ala Glu 
        35                  40                  45              


Lys Gln Tyr Lys Gly Ile Ile Asp Cys Val Val Arg Ile Pro Lys Glu 
    50                  55                  60                  


Gln Gly Phe Leu Ser Phe Trp Arg Gly Asn Leu Ala Asn Val Ile Arg 
65                  70                  75                  80  


Tyr Phe Pro Thr Gln Ala Leu Asn Phe Ala Phe Lys Asp Lys Tyr Lys 
                85                  90                  95      


Gln Leu Phe Leu Gly Gly Val Asp Arg His Lys Gln Phe Trp Arg Tyr 
            100                 105                 110         


Phe Ala Gly Asn Leu Ala Ser Gly Gly Ala Ala Gly Ala Thr Ser Leu 
        115                 120                 125             


Cys Phe Val Tyr Pro Leu Asp Phe Ala Arg Thr Arg Leu Ala Ala Asp 
    130                 135                 140                 


Val Gly Lys Gly Ala Ala Gln Arg Glu Phe His Gly Leu Gly Asp Cys 
145                 150                 155                 160 


Ile Ile Lys Ile Phe Lys Ser Asp Gly Leu Arg Gly Leu Tyr Gln Gly 
                165                 170                 175     


Phe Asn Val Ser Val Gln Gly Ile Ile Ile Tyr Arg Ala Ala Tyr Phe 
            180                 185                 190         


Gly Val Tyr Asp Thr Ala Lys Gly Met Leu Pro Asp Pro Lys Asn Val 
        195                 200                 205             


His Ile Phe Val Ser Trp Met Ile Ala Gln Ser Val Thr Ala Val Ala 
    210                 215                 220                 


Gly Leu Val Ser Tyr Pro Phe Asp Thr Val Arg Arg Arg Met Met Met 
225                 230                 235                 240 


Gln Ser Gly Arg Lys Gly Ala Asp Ile Met Tyr Thr Gly Thr Val Asp 
                245                 250                 255     


Cys Trp Arg Lys Ile Ala Lys Asp Glu Gly Ala Lys Ala Phe Phe Lys 
            260                 265                 270         


Gly Ala Trp Ser Asn Val Leu Arg Gly Met Gly Gly Ala Phe Val Leu 
        275                 280                 285             


Val Leu Tyr Asp Glu Ile Lys Lys Tyr Val 
    290                 295             


<210>  6
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic polynucleotide


<220>
<221>  misc_feature
<222>  (1)..(23)

<400>  6
cgccgccgtc tccaagacgg cgg                                               23


<210>  7
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic polynucleotide


<220>
<221>  misc_feature
<222>  (1)..(25)

<400>  7
ggggcggggc gcgcgcgcgt caggg                                             25


<210>  8
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic polynucleotide


<220>
<221>  misc_feature
<222>  (1)..(23)

<400>  8
cggctttgac tcccgggctc tgg                                               23


<210>  9
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic polynucleotide


<220>
<221>  misc_feature
<222>  (1)..(23)

<400>  9
aggtacgttc tgagatcgag ggg                                               23


